Investigator-reported vs adjudicated cause of death in the TIOSPIR™ trial

Robert Wise (Baltimore, United States of America), Robert Wise, Peter Kowey, George Austen, Andy Lawton, Achim Mueller, Norbert Metzdorf, Andy Fowler, Lorcan McGarvey

Source: International Congress 2015 – New data on established treatments for COPD
Session: New data on established treatments for COPD
Session type: Poster Discussion
Number: 1498
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert Wise (Baltimore, United States of America), Robert Wise, Peter Kowey, George Austen, Andy Lawton, Achim Mueller, Norbert Metzdorf, Andy Fowler, Lorcan McGarvey. Investigator-reported vs adjudicated cause of death in the TIOSPIR™ trial. Eur Respir J 2015; 46: Suppl. 59, 1498

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A randomised controlled trial of cognitive behavioural therapy (CBT) delivered by respiratory nurses to reduce anxiety in chronic obstructive pulmonary disease (COPD). (Trial registration - ISCRCTN55206395)
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016


Preferences for death and dying in patients with COPD
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016

Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial*): No impact on hospital admissions and quality of life (QOL)
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014


COPD specific comorbidities: A prospective, objective and controlled evaluation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007


Night time dyspnea in COPD: A study of a general population
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013


Causes of death in COPD patients in primary care setting - 6 years follow-up
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Safety of tiotropium in patients with cardiac events in the TIOSPIR™ trial
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015


Longitudinal changes in COPD patients in primary care
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013

CAT-score is a predictor for mortality in COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016


An integrated care management program (ICMP) for patients with severe COPD; mortality, hazards and causes
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015

Examination of variations in responder rates in COPD clinical trial outcomes
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013

COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT)
Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2015

COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Implementation of COPD phenotypes in real life
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Risk scores for predicting death in COPD patients
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014

Outcomes in patients with COPD during a 3 year follow-up
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015